Therapeutic options for targeting inflammatory osteoarthritis pain

PG Conaghan, AD Cook, JA Hamilton… - Nature Reviews …, 2019 - nature.com
Pain is the major symptom of osteoarthritis (OA) and is an important factor in strategies to
manage this disease. However, the current standard of care does not provide satisfactory …

[PDF][PDF] The genesis of pain in osteoarthritis: inflammation as a mediator of osteoarthritis pain

MJ Wood, RE Miller, AM Malfait - Clinics in geriatric medicine, 2022 - Elsevier
Chronic pain is a substantial personal and societal burden worldwide. Osteoarthritis (OA) is
one of the leading causes of chronic pain and is increasing in prevalence in accordance …

[HTML][HTML] Peripheral pain mechanisms in osteoarthritis

TL Vincent - Pain, 2020 - journals.lww.com
There is a well-established historical observation that structural joint damage by plain X-ray
correlates poorly with symptomatic disease in osteoarthritis (OA). This is often attributed to …

Mechanoflammation in osteoarthritis pathogenesis

TL Vincent - Seminars in arthritis and rheumatism, 2019 - Elsevier
Mechanical injury is the most important risk factor in osteoarthritis (OA) development.
Although once considered a passive disease of mechanical attrition, injury drives active …

Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis

AM Obeidat, MJ Wood, NS Adamczyk… - Nature …, 2023 - nature.com
Non-opioid targets are needed for addressing osteoarthritis pain, which is mechanical in
nature and associated with daily activities such as walking and climbing stairs. Piezo2 has …

[HTML][HTML] The changing sensory and sympathetic innervation of the young, adult and aging mouse femur

SR Chartier, SAT Mitchell, LA Majuta, PW Mantyh - Neuroscience, 2018 - Elsevier
Although bone is continually being remodeled and ultimately declines with aging, little is
known whether similar changes occur in the sensory and sympathetic nerve fibers that …

Of mice and men: converging on a common molecular understanding of osteoarthritis

TL Vincent - The Lancet Rheumatology, 2020 - thelancet.com
Despite an increasing burden of osteoarthritis in developed societies, target discovery has
been slow and there are currently no approved disease-modifying osteoarthritis drugs. This …

[HTML][HTML] CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy

JM Zarebska, A Chanalaris, C Driscoll… - Osteoarthritis and …, 2017 - Elsevier
Objective The role of inflammation in structural and symptomatic osteoarthritis (OA) remains
unclear. One key mediator of inflammation is the chemokine CCL2, primarily responsible for …

Peripheral mechanisms contributing to osteoarthritis pain

D Syx, PB Tran, RE Miller, AM Malfait - Current rheumatology reports, 2018 - Springer
Abstract Purpose of Review Osteoarthritis (OA) is the most common form of arthritis and a
major source of pain and disability worldwide. OA-associated pain is usually refractory to …

[HTML][HTML] Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration

Y Peng, X Qing, H Shu, S Tian, W Yang… - Biomaterials …, 2021 - ncbi.nlm.nih.gov
Low back pain is a vital musculoskeletal disease that impairs life quality, leads to disability
and imposes heavy economic burden on the society, while it is greatly attributed to …